{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:51:44Z","timestamp":1788591104044,"version":"build-2803163510"},"reference-count":5,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,6,3]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.<\/jats:p>","DOI":"10.1136\/bcr-2018-228509","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T06:04:06Z","timestamp":1560578646000},"page":"e228509","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy interactions and transition between services"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-8091","authenticated-orcid":false,"given":"Gazala","family":"Akram","sequence":"first","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Mitchell","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"2025082713094465000_12.6.e228509.1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1192\/pb.bp.108.024000","article-title":"Antipsychotic prescribing practice among child psychiatrists and community paediatricians","volume":"34","author":"Otasowie","year":"2010","journal-title":"Psychiatrist"},{"key":"2025082713094465000_12.6.e228509.2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.0508e15"},{"key":"2025082713094465000_12.6.e228509.3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.116.055483","article-title":"Perceptions and knowledge of antipsychotics among mental health professionals and patients","volume":"41","author":"Cahling","year":"2017","journal-title":"BJPsych Bull"},{"key":"2025082713094465000_12.6.e228509.4","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0015"},{"key":"2025082713094465000_12.6.e228509.5","unstructured":"Electronic Medicines compendium. Otsuka Pharmaceuticals, Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection (Aripiprazole Summary of Product Characteristics). https:\/\/www.medicines.org.uk\/emc\/product\/7965\/smpc."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-228509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:09:52Z","timestamp":1756325392000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-228509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":5,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,14]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bcr-2018-228509"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-228509","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}